Zhitong Finance App News, Zhaoyan New Pharmaceutical (06127.HK) announced that Ms. Li Jingying has resigned from the position of Joint Company Secretary of the Company and is no longer acting as the Company's authorized representative under section 3.05 of the Hong Kong Stock Exchange Limited Securities Listing Rules, and the Company's authorized representative to receive legal process documents and notices in Hong Kong on behalf of the Company under section 19A.13 (2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Hong Kong Laws), effective from October 28, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.